Biomarkers, Tumorfms-Like Tyrosine Kinase 3Gene Expression Profiling
Dr. Nibal Saad, MD
NPI1376807453PAC ID4981983475
- Medicare services, 2024
- 1,752
- Medicare patients, 2024
- 483
- Part D claims, 2024
- 2,891
- Publications
- 4
- Clinical trials
- 10
- Practice address
- 8111 S Emerson Ave, Indianapolis, IN 46237
- Practice phone
- Call (317) 528-5000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Saad's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Nibal Saad is a medical oncologist in Indianapolis, Indiana
Dr. Saad practices at Franciscan Health Indianapolis in Indianapolis, Indiana, part of Franciscan Alliance.
Dr. Saad's NPI, 1376807453, was assigned on July 3, 2012. Dr. Saad holds Indiana license 01080082A.
NPI and contact details
- NPI
- 1376807453NPI Registry (opens in a new tab)
- Medicare PAC ID
- 4981983475
- NPI enumeration date
- July 3, 2012
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (317) 528-5000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 46
- Medical school graduation
- 2006
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Nibal Saad practices at Franciscan Health Indianapolis in Indianapolis, Indiana
Dr. Saad's primary practice is Franciscan Health Indianapolis, at 8111 S Emerson Ave, Indianapolis, IN 46237 in Marion County. The practice phone is (317) 528-5000.
- Franciscan Health Indianapolis8111 S Emerson Ave, Indianapolis, IN 46237 · Marion CountyPhone(317) 528-5000
Source: Dmand AI Affiliation Data
Dr. Nibal Saad is affiliated with 7 sites of care and 1 medical group
Dr. Saad's primary practice is Franciscan Health Indianapolis in Indianapolis, Indiana, part of Franciscan Alliance. Dr. Saad is also affiliated with Franciscan Health Lafayette. The medical group on file is Franciscan Physician Network. Dmand AI also links Dr. Saad to 4 more hospitals and 1 group practice or clinic, each named with a free account.
Franciscan Health LafayetteFranciscan Physician Network4 hospitalsNames with a free account1 group practice or clinicName with a free account
See all 8 affiliations for Dr. SaadSources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Nibal Saad's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Saad practices, 7 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Franciscan Health Indianapolis | Available with a free account |
| +6 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Saad practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Franciscan Alliance and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Nibal Saad is one of 72 medical oncologists in Indiana
Medical oncology is Dr. Saad's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Saad is licensed in Indiana.
Specialties and state licenses
- Medical oncology, IndianaPrimary
Medical oncologists near Dr. Saad
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
72medical oncologists in Indiana28medical oncologists in Indianapolis2medical oncologists at Franciscan Health Indianapolis
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Nibal Saad billed Medicare for 1,752 services in 2024
CMS data shows 1,752 Medicare services from Dr. Saad across 11 procedure codes in 2024, for 483 Medicare patients. Medicare paid $137,182 for them.
Medicare services, 20241,752
Medicare patients483
Paid by Medicare$137,182
Procedure codes11
Dr. Saad's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 1,5622024: 1,75212%
Where Dr. Saad's Medicare services took place, 2024
- In an office98156%
- In a facility77144%
Dr. Saad compared with the Indiana median for medical oncologists, 2024
- Dr. Saad
- Indiana median
- Medicare services
- 1,752vs 91492% above
- Medicare patients
- 483vs 33644% above
- Part D claims
- 2,488vs 6543.8 times
Medians across 72 medical oncologists in Indiana with Dmand AI profiles that report each measure.
Dr. Saad's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Saad?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Saad and other medical oncologists in Indiana.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Nibal Saad treated 483 Medicare patients in 2024, average age 74
CMS counts 483 Medicare patients who saw Dr. Saad in 2024. The largest group is 65 to 74, with 195 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Saad's median patient age at 73, with 57% women.
Medicare patients, 2024483
Average age74
Average risk score2.15
Also on Medicaid14%
Dr. Saad's Medicare patients by age, 2024
Dr. Saad's Medicare patients by sex, 2024
- Women28158%
- Men20242%
Chronic conditions among Dr. Saad's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis45%
- Cancer44%
- Ischemic heart disease41%
- Mood disorders40%
- Depression39%
- Diabetes38%
Share of Medicare patients with each condition. A patient can have several.
Dr. Saad's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 73
Patient panel by sex, all payers
- Women57%
- Men43%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Nibal Saad wrote 2,891 Medicare Part D claims in 2024
In 2024, Dr. Saad wrote 2,891 Medicare Part D claims for 360 patients. 82% of them were for generic drugs. CMS names the drug for 2,488 of them, across 61 drugs with 11 or more claims each, at $3,559,634 in total drug cost. In 2023, CMS named 1,501 claims across 46 drugs.
Part D claims, 20242,891
Drugs named by CMS61
Total drug cost$3.6M
Part D patients360
Dr. Saad's Part D claims by kind of drug, 2024
- Generic2,364 claims82%
- Brand-name527 claims18%
Dr. Saad's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Saad's Part D claims, 2024
- Opioids8%244 of 2,891 claims
- Antibiotics5%154 of 2,891 claims
- Antipsychotics, patients 65 and over2%71 of 2,891 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,5012024: 2,48866%
Drugs named by CMS: 61 in 2024, 46 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Nibal Saad offers telehealth to Medicare patients
Dr. Saad accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Saad as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Find medical oncologists like Dr. Saad by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Nibal Saad has 4 publications on record
Dmand AI links 4 papers to Dr. Saad, published from 2017 to 2019. Dr. Saad's most frequent co-authors are Alina Basnet, MD, Ankit Anand, MD and Sam Benjamin, MD.
Papers4
Years published2017 to 2019
Dr. Saad's most frequent co-authors
Recent publications by Dr. Saad
Anticancer Res
Antibodies, MonoclonalBrain NeoplasmsImmunotherapy
See who Dr. Saad researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Saad works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Nibal Saad has worked on 10 clinical trials
Dmand AI links Dr. Saad to 10 clinical trials, 5 of them phase 2 studies. 10 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Breast Carcinoma In Situ. National Cancer Institute (NCI) sponsors the most, 10.
Clinical trials with Dr. Saad by phase
- NonePhase 1: no trials
- 5Phase 2: 5 trials
- 4Phase 3: 4 trials
- NonePhase 4: no trials
Conditions in Dr. Saad's trials
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Bronchogenic
- Breast Carcinoma In Situ
- Cystadenocarcinoma, Mucinous
- Lung Neoplasms
Investigators on the most trials with Dr. Saad
- Omer Muhammad Toor, MD9 shared trials
- Sunitha Vemulapalli, MD5 shared trials
- Haythem Y. Ali, MD4 shared trials
Recent clinical trials with Dr. Saad
Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO (ACCIO) (opens in a new tab)
RecruitingPhase 3
Carcinoma, Non-Small-Cell LungCarcinoma, BronchogenicCarboplatinCisplatinGemcitabine Hydrochloride
Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer (opens in a new tab)
Active, not recruitingPhase 2
Lung NeoplasmsThoracic NeoplasmsNivolumabCabozantinib S-malateDocetaxel
Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer (opens in a new tab)
Active, not recruitingPhase 2
Urinary Bladder NeoplasmsUrinary Bladder DiseasesPembrolizumabGemcitabine Hydrochloride
Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP Trial (opens in a new tab)
Active, not recruitingPhase 3
PembrolizumabRadiation Therapy
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Nibal Saad received $3,045 in industry payments from 2017 to 2025
CMS Open Payments shows 119 general payments to Dr. Saad from 45 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 80% of the total. Seagen Inc. paid the most, $274.
General payments to Dr. Saad by program year, 2017 to 2025
General payments to Dr. Saad by kind, 2017 to 2025
$3Kin total
- Food and beverage$2,44680%
- Education$59920%
Companies that paid Dr. Saad the most, 2017 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Nibal Saad's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Nibal Saad
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Nibal Saad's NPI number?
Dr. Nibal Saad's NPI number is 1376807453. It was assigned on July 3, 2012, and it is active in the NPI Registry.
What kind of doctor is Dr. Nibal Saad?
Dr. Nibal Saad is a medical oncologist in Indianapolis, Indiana. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Nibal Saad practice?
Dr. Saad practices at 8111 S Emerson Ave, Indianapolis, IN 46237. Dr. Saad's primary practice is Franciscan Health Indianapolis in Indianapolis, Indiana, part of Franciscan Alliance. Dmand AI also links Dr. Saad to 4 hospitals and 1 group practice or clinic.
What is Dr. Nibal Saad's office phone number?
The practice phone on file for Dr. Saad is (317) 528-5000.
What is Dr. Nibal Saad's medical license number?
Dr. Saad holds Indiana license 01080082A.
Which hospitals is Dr. Nibal Saad affiliated with?
Dr. Saad practices at Franciscan Health Indianapolis in Indianapolis, Indiana. Dr. Saad is also affiliated with Franciscan Health Lafayette. Dmand AI links Dr. Saad to 4 more hospitals.
What medical group is Dr. Nibal Saad part of?
Dr. Saad is linked to Franciscan Physician Network.
Does Dr. Nibal Saad accept Medicare?
Yes. CMS data shows Dr. Saad billed Medicare for 1,752 services in 2024, and Dr. Saad accepts Medicare assignment.
Does Dr. Nibal Saad offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Saad as offering telehealth services.
How many Medicare patients does Dr. Nibal Saad see?
CMS counts 483 Medicare patients who saw Dr. Saad in 2024, with an average age of 74.
Show 6 more questionsShow fewer questions
What services does Dr. Nibal Saad bill to Medicare?
In 2024, Dr. Saad's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99215) and office visit, established patient (99213).
What drugs does Dr. Nibal Saad prescribe most?
In 2024 Medicare Part D data, Dr. Saad's most prescribed drugs by claims were Eliquis, Ondansetron ODT and Letrozole.
Has Dr. Nibal Saad received payments from drug or device companies?
CMS Open Payments shows $3,045 in general payments to Dr. Saad from 45 companies from 2017 to 2025. The largest total came from Seagen Inc.
How long has Dr. Nibal Saad been practicing?
Dr. Saad graduated from medical school in 2006, 20 years ago.
Does Dr. Nibal Saad do research?
Dmand AI links 4 publications to Dr. Saad, published from 2017 to 2019. Dr. Saad has worked on 10 clinical trials.
Who does Dr. Nibal Saad publish with?
Dr. Saad's most frequent co-authors are Alina Basnet, MD (3 shared papers), Ankit Anand, MD (1 shared paper) and Sam Benjamin, MD (1 shared paper).
Selling to medical oncology practices?
See medical oncologists in Indiana by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card